Article

New system classifies vitreomacular disease, provides common language

An international panel of ophthalmologists have developed a classification system of vitreomacular diseases, with the goals of objectivity based on optical coherence tomography (OCT) findings and ease of use.

 

Boston-An international panel of ophthalmologists have developed a classification system of vitreomacular diseases, with the goals of objectivity based on optical coherence tomography (OCT) findings and ease of use.

The new imaging-based classification system was needed because the Gass classification for macular holes was outdated. The Gass system was devised decades before the introduction of spectral-domain OCT, which has provided a better understanding of the pathogenesis of diseases of the vitreomacular interface diseases and is predictive of surgical outcomes.

The classification system was also needed because of the recently FDA-approved ocriplasmin (Jetra, ThromboGenics), a new therapy for some diseases, said Jay Duker, MD, professor and chairman of ophthalmology, Tufts University School of Medicine, Boston.

“We wanted the system to be applicable to clinical practice, useful for clinical trials, and predictive of surgical outcomes,” Dr. Duker said. “The overall goal was for ophthalmologists to speak a common language about these diseases.”

One finding (vitreomacular adhesion) and four diseases (vitreomacular traction, full-thickness macular hole, lamellar macular hole, and epiretinal membrane) are included in the classification, which the panel published in Ophthalmology (2013;120:261119).

When converting from the old Gass classification system to the new international classification system:

·      Stage 0 macular hole is equivalent to vitreomacular adhesion in the contralateral eye

·      Stage 1 macular hole is equivalent to vitreomacular traction

·      Stage 2 macular hole is equivalent to full-thickness macular hole (small/medium hole with/without vitreomacular traction)

·      Stage 3 macular hole is equivalent to full-thickness macular hole (medium/large hole with/without vitreomacular traction)

·      Stage 4 macular hole is equivalent to full-thickness macular hole (vitreomacular traction released with any size macular hole)

“Vitreomacular adhesion is a normal stage of progression of posterior vitreous detachment,” Dr. Duker noted. “Abnormalities result from persistence of adhesion with traction (vitreomacular traction), which can lead to severe retinal anatomic abnormalities, full-thickness macular holes, epiretinal membranes, lamellar macular holes, and macular schisis.”

 

For more articles in this issue of Ophthalmology Times eReport, click here.

 

 

To receive weekly clinical news and updates in ophthalmology, subscribe to the Ophthalmology Times eReport.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times)  ASCRS 2025: Joaquin De Rojas, MD, leverages machine learning model to predict arcuate outcomes
(Image credit: Ophthalmology Times) ASCRS 2025: AnnMarie Hipsley, DPT, PhD, presents VESA for biomechanical simulation of presbyopia progression
Shehzad Batliwala, DO, aka Dr. Shehz, discussed humanitarian ophthalmology and performing refractive surgery in low-resource, high-risk areas at the ASCRS Foundation Symposium.
(Image credit: Ophthalmology Times) ASCRS 2025: Advancing vitreous care with Inder Paul Singh, MD
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
© 2025 MJH Life Sciences

All rights reserved.